Automated Phenotyping With Artificial Intelligence Predicts Future Advanced Neoplasia Risk in Colitis-Associated Low-Grade Dysplasia
Year: 2026
Type: article
Abstract: The ability to precisely determine future risk of advanced neoplasia (AN; high-grade dysplasia and/or colorectal cancer [CRC]) in patients with ulcerative colitis (UC) and low-grade dysplasia (LGD) is a major unmet need. Given the uncertainty in existing prognostic data, current guidelines advise incorporating expert opinion into management decisions, which can be challenging and imprecise.1 In addition to supporting clinician decision-making, having quantitative estimates of cancer risk also increases patients’ ability to make informed shared decisions on surgery vs continued intensive surveillance following a LGD diagnosis.2
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,470
OpenAlex ID: W7129657293
